Gupta VK, Gupta K, Sonker P, Mishra M, Kumar A. Role of lysophosphatidic acid in the regulation of immune cells and hematological malignancies. Prostaglandins Other Lipid Mediat. 2025;180:107028. https://doi.org/10.1016/j.prostaglandins.2025.107028.

Article  CAS  PubMed  Google Scholar 

Kano K, Aoki J, Hla T. Lysophospholipid mediators in health and disease. Annu Rev Pathol. 2022;17:459–83. https://doi.org/10.1146/annurev-pathol-050420-025929.

Article  CAS  PubMed  Google Scholar 

Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, et al. Autotaxin has lysophospholipase D activity leading to tumour cell growth and motility by lysophosphatidic acid production. J Cell Biol. 2002;158:227–33. https://doi.org/10.1083/jcb.200204026.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta. 2008;1781:513–8. https://doi.org/10.1016/j.bbalip.2008.06.005.

Article  CAS  PubMed  Google Scholar 

Perrakis A, Moolenaar WH. Autotaxin: structure-function and signaling. J Lipid Res. 2014;55:1010–8. https://doi.org/10.1194/jlr.R046391.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yung YC, Stoddard NC, Chun J. LPA receptor signaling: pharmacology, physiology, and pathophysiology. J Lipid Res. 2014;55:1192–214. https://doi.org/10.1194/jlr.R046458.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, et al. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol. 2010;50:157–86. https://doi.org/10.1146/annurev.pharmtox.010909.105753.

Article  CAS  PubMed  Google Scholar 

Kihara Y, Maceyka M, Spiegel S, Chun J. Lysophospholipid receptor nomenclature review: IUPHAR review 8. Br J Pharmacol. 2014;171:3575–94. https://doi.org/10.1111/bph.12678.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Idzko M, Laut M, Panther E, Sorichter S, Durk T, Fluhr JW, et al. Lysophosphatidic acid induces chemotaxis, oxygen radical production, CD11b up-regulation, Ca2+ mobilization, and actin reorganization in human eosinophils via pertussis toxin-sensitive G proteins. J Immunol. 2004;172:4480–5. https://doi.org/10.4049/jimmunol.172.7.4480.

Article  CAS  PubMed  Google Scholar 

Hashimoto T, Yamashita M, Ohata H, Momose K. Lysophosphatidic acid enhances in vivo infiltration and activation of guinea pig eosinophils and neutrophils via a Rho/ROCK-mediated pathway. J Pharmacol Sci. 2003;91:8–14. https://doi.org/10.1254/jphs.91.8.

Article  CAS  PubMed  Google Scholar 

Hashimoto T, Ohata H, Momose K. Lysophosphatidic acid induces plasma exudation and histamine release in mice via LPA receptors. J Pharmacol Sci. 2006;100:82–7. https://doi.org/10.1254/jphs.FPJ05030X.

Article  CAS  PubMed  Google Scholar 

Itagaki K, Hauser CJ. Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils. J Leukoc Biol. 2005;77:181–9. https://doi.org/10.1189/jlb.0704390.

Article  CAS  PubMed  Google Scholar 

Zhao C, Sardella A, Chun J, Poubelle PE, Fernandes MJG, Bourgoin SG. TNF-alpha promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines. J Lipid Res. 2011;52:1307–18. https://doi.org/10.1194/jlr.M008045.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tager AM, LaCamera P, Shea BS, Campanella GSV, Selman M, Zhao Z, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med. 2008;14:45–54. https://doi.org/10.1038/nm1685.

Article  CAS  PubMed  Google Scholar 

Swaney JS, Chapman C, Correa LD, Stebbins KJ, Broadhead AR, Bain G, et al. A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br J Pharmacol. 2010;160:1699–713. https://doi.org/10.1111/j.1476-5381.2010.00828.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oda SK, Strauch P, Fujiwara Y, Al-Shami A, Oravecz T, Tigyi G, et al. Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression. Cancer Immunol Res. 2013;1:245–55. https://doi.org/10.1158/2326-6066.CIR-13-0043-T.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turner JA, Fredrickson MA, D’Antonio M, et al. Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity. Nat Commun. 2023;14:3214. https://doi.org/10.1038/s41467-023-38933-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hayakawa K, Kurano M, Ohya J, Oichi T, Kano K, Nishikawa M, et al. Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis. Sci Rep. 2019;9:9144. https://doi.org/10.1038/s41598-019-45742-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Plastira I, Bernhart E, Goeritzer M, DeVaney T, Reicher H, Hammer A, et al. Lysophosphatidic acid via LPA-receptor 5/protein kinase D-dependent pathways induces a motile and pro-inflammatory microglial phenotype. J Neuroinflammation. 2017;14:253. https://doi.org/10.1186/s12974-017-1024-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Plastira I, Bernhart E, Goeritzer M, Reicher H, Kumble VB, Kogelnik N, et al. MAPK signaling determines lysophosphatidic acid-induced inflammation in microglia. J Neuroinflammation. 2020;17:127. https://doi.org/10.1186/s12974-020-01809-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joshi L, Plastira I, Bernhart E, Reicher H, Kumble VB, Siess W, et al. Inhibition of autotaxin and lysophosphatidic acid receptor 5 attenuates neuroinflammation in LPS-activated BV-2 microglia and a mouse model of endotoxemia. Int J Mol Sci. 2021;22:8519. https://doi.org/10.3390/ijms22168519.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaire BP, Sapkota A, Song MR, Choi JW. Lysophosphatidic acid receptor 1 plays critical roles in microglial activation and brain damage after transient focal cerebral ischemia. J Neuroinflammation. 2019;16:170. https://doi.org/10.1186/s12974-019-1555-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lundequist A, Boyce JA, Austen KF. Lysophosphatidic acid, acting through LPA5, induces mast cell activation and chemokine production. PLoS ONE. 2011;6:e18192. https://doi.org/10.1371/journal.pone.0018192.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maher TM, van der Aar EM, Van de Steen O, Allamassey L, Desrivot J, Dupont S, et al. Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: the ISABELA 1 and 2 randomized clinical trials. JAMA. 2023;329:1567–78. https://doi.org/10.1001/jama.2023.5355.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mathew D, Torres RM. Lysophosphatidic acid is an inflammatory lipid exploited by cancers for immune evasion via mechanisms similar and distinct from CTLA-4 and PD-1. Front Immunol. 2021;11:531910. https://doi.org/10.3389/fimmu.2020.531910.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kosinska MK, Liebi